GE HealthCare Technologies (GEHC)
Live data on GE HealthCare Technologies: price, returns, valuation, earnings and insider trades.
About GE HealthCare Technologies
GE HealthCare Technologies (GEHC) is a member of the S&P 500 in the Health Care sector.
As an S&P 500 company it is held by every S&P 500 index fund, including SPY, VOO and IVV, and by total-market funds such as VTI, and its sector is tracked by the Health Care Select Sector SPDR Fund (XLV).
The cards at the top of this page update from live market data: price and returns against the S&P 500, the deepest drawdowns and how long they took to recover, valuation multiples, margins and growth, the next earnings date with recent results, insider buying and selling, technical levels, how closely the shares move with stocks, bonds and gold, and the latest news. The full research report underneath adds a discounted cash flow valuation, peer multiples, the financial statements and analyst consensus.
Is GEHC a good stock to buy?
This page does not rate stocks. It puts the evidence in one place: what you pay (the valuation multiples), what you get (growth, margins and returns on equity), and what owning it has felt like (drawdowns, volatility and calendar-year returns). Compare those against the peers linked below and your own time horizon. General information, not advice.
What is GE HealthCare Technologies's fair value?
Run the full report on this page. It builds a discounted cash flow valuation from the company's own filings, with growth, discount rate and terminal growth you can change, and sets it against what comparable companies trade at. Both are estimates that move with their assumptions, which is why the report shows its inputs.
Which ETFs hold GEHC?
Every fund tracking the S&P 500 holds it in proportion to its market value, which includes SPY, VOO and IVV, and total-market funds such as VTI hold it too. Within its sector, the Health Care Select Sector SPDR Fund (XLV) holds it.
When does GE HealthCare Technologies report earnings?
The Earnings card above shows the next scheduled report once the company has announced the date, with the consensus estimate for earnings per share and how the last four quarters compared with expectations.